ArticleFrontiers in psychiatry2026
Associations of cerebrospinal fluid metal ion profiles with depressive symptoms in active smokers: a cross-sectional network analysis.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Smokers are more likely to report depressive symptoms, on the other hand, individuals with depression are also more likely to initiate smoking. In a recent study, higher CSF concentration of magnesium, zinc, iron, lead, lithium, and aluminum were reported among active smokers. This study investigated whether the disruption of central metal homeostasis in active smokers is associated with self-reports of depressive symptoms. Methods: CSF samples from 161 Chinese male patients who underwent anterior cruciate ligament reconstruction surgical operation following knee joint injuries were obtained. Among the 161 male patients, 57 male patients were active smokers while 104 patients reported never engaged in any form of smoking. Depressive symptoms were measured via Beck Depression Inventory (BDI) self-reports. CSF concentrations of 8 metal ions were quantified by atomic absorption spectrophotometry. Group comparisons, correlation analyses, mixed graphical model network analyses, and moderation models were performed to examine associations among smoking, CSF metal ions, and depressive symptoms. Results: Active smokers had higher BDI total scores and higher CSF concentrations of magnesium, zinc, iron, lead, lithium, and aluminum than non-smokers. Higher BDI total scores were associated with higher CSF concentration of zinc, iron, lead, and aluminum. Network analysis revealed iron, zinc, and lead ranked the highest in terms of strength, expected influence, and closeness among the 8 metal ions. With iron as an important association node among the three in the metal ion network observed, simultaneously significantly associated with BDI total scores. Further analyses revealed smoking was positively associated with depressive symptoms, and the interaction between smoking and iron significantly predicted BDI total scores. Additional analyses revealed that concentrations of iron in CSF also significantly interacted with zinc and lead. Conclusions: Iron is an important associated node that connects various other metal ions to self-reports of depressive symptoms. This finding shed light upon the interrelationships among smoking status, depressive symptoms, and metal ions in CSF, providing partial evidence supporting the relevance of central metal dysregulation to the smoking-depressive symptoms among male smokers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.